Bio View Stock

Bio View Debt

The Debt of Bio View (BIOV.TA) as of Sep 3, 2026 is 1.98 M ILS. In the previous year, Debt was 3.51 M ILS — a change of -43.41% (lower).

Debt

1.98 MILS

YoY

-43.41%

Last updated:

In 2026, Bio View's total debt was 1.98 M ILS, a -43.41% change from the 3.51 M ILS total debt recorded in the previous year.

The Bio View Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt
Date
Debt
Jan 1, 2017
0.00 ILS
Jan 1, 2018
0.00 ILS
Jan 1, 2019
2.49 M ILS
Jan 1, 2020
1.46 M ILS
Jan 1, 2021
4.61 M ILS
Jan 1, 2022
4.06 M ILS
Jan 1, 2023
3.51 M ILS
Jan 1, 2024
1.98 M ILS
The Bio View Debt history
YEARDebtYoY
1.98 MILS-43.41%
3.51 MILS-13.60%
4.06 MILS-11.94%
4.61 MILS+215.18%
1.46 MILS-41.26%
2.49 MILS—
0.00ILS—
0.00ILS—
0.00ILS—
0.00ILS—
0.00ILS—
Access this data via the Eulerpool API
Get Free API Key

Bio View Stock analysis

What does Bio View do? Bio View is one of the most popular companies on Eulerpool.

Debt Details

Understanding Bio View's Debt Structure

Bio View's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Bio View's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Bio View’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Bio View’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Bio View stock

Debt of Bio View is 1.98 M ILS in 2026.

Debt of Bio View changed from 3.51 M ILS to 1.98 M ILS, representing a -43.41% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Debt Bio View since 2006 – with annual values, charts, and detailed analysis.

Debt's ILS is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Debt's Bio View historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — Bio View

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Bio View